Bausch Health Companies INC. (BHC) — 10-Q Filings

All 10-Q filings from Bausch Health Companies INC.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

Bausch Health Swings to Profit, Boosts Sales Amid Debt Restructuring — Oct 30, 2025 Risk: medium
Bausch Health Companies Inc. reported a significant turnaround in its financial performance for the nine months ended September 30, 2025, achieving a net income
Bausch Health Sees Q2 Revenue Jump, Product Sales Drive Growth — Jul 31, 2025 Risk: medium
Bausch Health Companies Inc. reported total revenues for the three months ended June 30, 2025, and 2024, and for the six months ended June 30, 2025, and 2024. T
Bausch Health Files Q1 2025 10-Q — May 1, 2025 Risk: medium
Bausch Health Companies Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Valeant Pharmaceuticals International, Inc., is
Bausch Health Files Q3 2024 10-Q — Oct 31, 2024 Risk: medium
Bausch Health Companies Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Valeant Pharmaceuticals International, Inc.
Bausch Health Files Q2 2024 10-Q — Aug 1, 2024 Risk: medium
Bausch Health Companies Inc. filed its 10-Q for the period ending June 30, 2024. The filing covers the company's financial performance and operations during the
Bausch Health Companies Inc. Files 10-Q for Period Ending March 31, 2024 — May 2, 2024 Risk:
Bausch Health Companies Inc. (BHC) filed a Quarterly Report (10-Q) with the SEC on May 2, 2024. Bausch Health Companies Inc. filed a 10-Q report for the period

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX